chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 65.0
Sex: F
Vaccine: COVID19
Symptoms: Arthralgia, Blood cholesterol, Blood pressure measurement, Limb injury, Movement disorder
Clinical narrative: Arm started hurting; Arm started burning instantly; Arm sore; Trouble raising it up; Pain in neck; Pain in shoulder; This is a spontaneous report from a contactable consumer (patient). A 65-year-old non-pregnant female patient received first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, formulation: solution for injection, lot number: EN6199), via an unspecified route of administration, administered in left arm on 04Mar2021 14:45 (at the age of 65-years-old) as single dose for COVID-19 immunization. The patient's medical history included diabetic, thyroid, high cholesterol, high blood pressure. The patient previously took demerol and experienced known allergies. The patient's concomitant medication included metoprolol. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. On 04Mar2021 after the vaccination, the patient experienced arm started hurting/burning instantly. radiated to entire arm. arm sore, pain in neck and pain in shoulder. It was reported arm started hurting/burning instantly. Radiated to entire arm. arm sore. Trouble raising it up. Later pain in neck and shoulder. Been almost 18hours since injection. Still in pain. The patient underwent lab tests and procedures which included on an unspecified date blood cholesterol: high and blood pressure measurement: high. Since the vaccination, the patient has not been tested for COVID-19. The patient did not receive any treatment for the adverse event. The outcome of events was not recovered.  No follow-up attempts are possible. No further information is expected.
Age: 65.0
Sex: F
Vaccine: COVID19
Symptoms: Neck pain, Pain in extremity, Thermal burn
Clinical narrative: Arm started hurting; Arm started burning instantly; Arm sore; Trouble raising it up; Pain in neck; Pain in shoulder; This is a spontaneous report from a contactable consumer (patient). A 65-year-old non-pregnant female patient received first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, formulation: solution for injection, lot number: EN6199), via an unspecified route of administration, administered in left arm on 04Mar2021 14:45 (at the age of 65-years-old) as single dose for COVID-19 immunization. The patient's medical history included diabetic, thyroid, high cholesterol, high blood pressure. The patient previously took demerol and experienced known allergies. The patient's concomitant medication included metoprolol. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. On 04Mar2021 after the vaccination, the patient experienced arm started hurting/burning instantly. radiated to entire arm. arm sore, pain in neck and pain in shoulder. It was reported arm started hurting/burning instantly. Radiated to entire arm. arm sore. Trouble raising it up. Later pain in neck and shoulder. Been almost 18hours since injection. Still in pain. The patient underwent lab tests and procedures which included on an unspecified date blood cholesterol: high and blood pressure measurement: high. Since the vaccination, the patient has not been tested for COVID-19. The patient did not receive any treatment for the adverse event. The outcome of events was not recovered.  No follow-up attempts are possible. No further information is expected.
Age: 47.0
Sex: F
Vaccine: COVID19
Symptoms: Dizziness, Dysgeusia, Taste disorder
Clinical narrative: weird taste; Lightheaded; A funny taste in my mouth; This is a spontaneous report from a contactable consumer (patient).  A 47-years-old non pregnant female patient received first dose of bnt162b2 (BNT162B2, solution for injection, Batch/Lot number: not reported) administered in left arm via an unknown route of administration, on 04Mar2021 at 12:30pm as single dose for covid-19 immunization. Medical history included multiple sclerosis, complex regional pain syndrome, fibromyalgia, hypertension, hypothyroidism, hypokalaemic syndrome, intervertebral disc degeneration, vitamin d deficiency, hypersensitivity. On 04Mar2021 at 13:30pm, the patient was lightheaded for about 4 hours, a funny taste in mouth started about 30 minutes after the vaccine and lasted a few hours but food still has a weird taste the next day. No treatment was received for the events. The outcome of the events was recovered with sequelae. It was reported that patient received no other vaccine in four weeks. In two weeks, patient received other unspecified vaccine first dose on left arm on o4Mar2021. The patient was not diagnosed with covid prior vaccination and not tested for covid post vaccination. The patient had known allergies. No follow up attempts were possible, information about lot/batch number cannot be obtained.
Age: 36.0
Sex: F
Vaccine: COVID19
Symptoms: Circumoral swelling, Hypoaesthesia, Paraesthesia, Pharyngeal swelling, Throat irritation
Clinical narrative: Face tingling and numbness; Face tingling and numbness; swelling around mouth; swelling anad itchiness of throat; swelling anad itchiness of throat; This is a spontaneous report from a contactable consumer (Patient, self-reported).   A 36-years-old (non pregnant) female patient received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Solution for injection, Batch/Lot Number: EN6205), via an unspecified route of administration, administered in Left arm on 04Mar2021 14:45 (At 36-years-old) as a single dose for COVID-19 immunisation. Medical history included asthma from an unspecified date and unknown if ongoing, known allergies: Penicillin. Concomitant medications taken in two weeks included budesonide, formoterol fumarate (SYMBICORT) (MANYFACTURER UNKNOWN) 160/4.5 from an unspecified date and unknown if ongoing. No other vaccine in four weeks. Patient did not received any vaccine on same date. Patient was not diagnosed with COVID-19 prior vaccination. Patient has not been tested for COVID-19, post vaccination.   On 04Mar2021 15:45, patient experienced Face tingling and numbness, swelling around mouth, swelling and itchiness of throat, very minor and occurred after the 15 minute wait time - about 20 minutes after vaccination, symptoms disappeared approx. 10 minutes after appearing. Patient did not received treatment for adverse events. Events were non-serious. Outcome of the reported events had recovered on 04Mar2021.  No follow-up attempts are possible. No further information is expected.
Age: 47.0
Sex: F
Vaccine: COVID19
Symptoms: Dysgeusia, Saliva discolouration, Tongue discolouration
Clinical narrative: metallic taste; salivating black; tongue is stained black; This is a spontaneous report from a contactable consumer (patient herself). A 47-year-old female patient received her first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE) intramuscular on the left upper arm on 04Mar2021 at 14:00 (at the age of 47-year old) (Batch/Lot number EL9264) at single dose for Covid-19 immunization. Relevant medical history included allergy to doxycycline described as vomiting from in 1990s or 1990. Concomitant medications were not reported. Starting about 07:45 on 05Mar2021 when she woke up she had a metallic taste in her mouth; she began salivating black, spitting up black saliva which turned her tongue black, tongue was stained black in stripes. She still had the metallic taste in the back of her throat; but was not actively spitting up black saliva any longer. The outcome of metallic taste was recovering, the outcome of other events was unknown.  No follow-up attempts are possible. No further information is expected.
Age: 44.0
Sex: F
Vaccine: COVID19
Symptoms: Anxiety, Chills, Dysgeusia, Feeling abnormal, Malaise
Clinical narrative: Bad body aches from lower back down legs; Unwell feeling all night; feverish; chills; bad taste in mouth; restless; Stomach turning; A red very warm blotch on my arm around the injection site; Anxiety; Feelings disappeared then came back not as harsh around 30 hours after; This is a spontaneous report from a contactable consumer (patient) or other non hcp. A 44-years-old non-pregnant female patient received bnt162b2 (BNT162B2, Solution for injection), via an unspecified route of administration on an unspecified date (Batch/Lot Number: EN8581) as unknown, single for covid-19 immunisation. Medical history included CVC (Central venous catheter). Concomitant medications included Metoprolol succinate 25 mg, Omeprazole 40 mg, Cetirizine hydrochloride. Patient had known allergies. Patient did not receive any other vaccine within 4 weeks. Patient neither diagnosed with COVID-19 prior to vaccination nor been tested for COVID-19 post vaccination. On an unknown date, the patient experienced bad body aches from lower back down legs 12 hours later, unwell feeling all night, feverish, chills and bad taste in mouth, restless, stomach turning. Her feelings disappeared then came back not as harsh around 30 hours after. Patient went to work feeling ok thought she was back to normal but when she showered, she noticed a red very warm blotch on her arm around the injection site which slightly disappeared after 12 hours and had anxiety. The patient was recovering from the event red very warm blotch on her arm around the injection site. The outcome of all other events was reported as unknown.  No follow-up attempts are possible. No further information is expected.
Age: 44.0
Sex: F
Vaccine: COVID19
Symptoms: Nausea, Pain, Pyrexia, Rash macular, Restlessness
Clinical narrative: Bad body aches from lower back down legs; Unwell feeling all night; feverish; chills; bad taste in mouth; restless; Stomach turning; A red very warm blotch on my arm around the injection site; Anxiety; Feelings disappeared then came back not as harsh around 30 hours after; This is a spontaneous report from a contactable consumer (patient) or other non hcp. A 44-years-old non-pregnant female patient received bnt162b2 (BNT162B2, Solution for injection), via an unspecified route of administration on an unspecified date (Batch/Lot Number: EN8581) as unknown, single for covid-19 immunisation. Medical history included CVC (Central venous catheter). Concomitant medications included Metoprolol succinate 25 mg, Omeprazole 40 mg, Cetirizine hydrochloride. Patient had known allergies. Patient did not receive any other vaccine within 4 weeks. Patient neither diagnosed with COVID-19 prior to vaccination nor been tested for COVID-19 post vaccination. On an unknown date, the patient experienced bad body aches from lower back down legs 12 hours later, unwell feeling all night, feverish, chills and bad taste in mouth, restless, stomach turning. Her feelings disappeared then came back not as harsh around 30 hours after. Patient went to work feeling ok thought she was back to normal but when she showered, she noticed a red very warm blotch on her arm around the injection site which slightly disappeared after 12 hours and had anxiety. The patient was recovering from the event red very warm blotch on her arm around the injection site. The outcome of all other events was reported as unknown.  No follow-up attempts are possible. No further information is expected.
Age: 25.0
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site pain
Clinical narrative: Muscle pain at injection site; This is a spontaneous report from a non-contactable consumer (patient). A 25-year-old non pregnant female patient received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, Lot number: EL3248) via an unspecified route of administration on 04Mar2021 09:45 am (at the age of 25-year-old) as unknown, single dose for COVID-19 immunization. The patient medical history and concomitant medications were not reported. The patient had no known allergy. COVID prior vaccination was none. Since the vaccination, patient had not been tested for COVID-19. COVID tested post vaccination was none. On 04Mar2021, the patient experienced muscle pain at the injection site. The patient did not receive any treatment for the event. The outcome of the event was recovering.  No follow-up attempts are possible. No further information is expected.
Sex: M
Vaccine: COVID19
Symptoms: Pain in extremity
Clinical narrative: arm was barely sore; This is a spontaneous report from a contactable consumer (patient). A 63-year-old male consumer received second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, Lot number was not reported) via an unspecified route of administration on an unspecified date as first dose, single for COVID-19 immunization. The Patient medical history included knee pain for which he periodically gets a steroid injection, and he will eventually have surgery. He has a doctor appointment coming up and wonders if he can get the steroid injection in his knee. He has been referred all over the place looking for answers and no one can tell him. He was referred to Pfizer. The patient concomitant medications were not reported. The patient reported that his arm was barely sore after first Pfizer covid vaccine injection and after the second dose, his arm was sore for 24 hours and he got a little headache. The patient stated that he was on oral steroids and got the flu vaccine and he got sick as a dog. The outcome of the event was unknown.  No follow-up attempts are possible; information about lot/batch number cannot be obtained.
Age: 35.0
Sex: M
Vaccine: COVID19
Symptoms: Rash, Urticaria
Clinical narrative: Rash/Hives occurring two days after vaccination; Rash/Hives occurring two days after vaccination; This is a spontaneous report from a contactable other hcp. A 35-years-old male patient received second dose of bnt162b2 (BNT162B2 (PFIZER-BIONTECH COVID-19 MRNA VACCINE, Solution for injection, Batch/Lot number was not reported) intramuscular, administered in arm right on 19Feb2021as second dose, single for COVID-19 immunization. It was reported that the patient had no allergies. The patient medical history and concomitant was not reported. The patient did not receive any other vaccine in four weeks. Prior to vaccination patient was not diagnosed with COVID was unknown. Post vaccination patient did not test for COVID. Patient previously took first dose of bnt162b2 (BNT162B2, solution for injection, Batch/Lot Number was not reported) via an unspecified route of administration, administered on unknown date as first dose, single for COVID-19 immunization. It was reported that on 21Feb2021 the patient experienced Rash/Hives occurring two days after vaccination. Treated with 5 days of prednisone and hydroxyzine without relief. Therapeutic measures were taken as a result of rash/hives occurring two days after vaccination. The outcome of the events was not recovered.  No follow-up attempts are possible; information about lot/batch number cannot be obtained.
Sex: F
Vaccine: COVID19
Symptoms: Dyspnoea, Fatigue, Malaise, Paraesthesia
Clinical narrative: L arm tingling; malaise; shortness of breath; tired/fatigue; This is a spontaneous report from a non-contactable other healthcare professional. A 66-years-old female patient the first dose of received bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EN6203), via an unspecified route of administration on an unspecified date as a single dose for covid-19 immunization. The patient's medical history and concomitant medications were not reported.  The patient experienced tired/fatigue on 05Mar2021, l arm tingling, malaise and shortness of breath on an unspecified date. During her 15-minute waiting period after the injection, the patient began to experience L arm tingling. Patient complains of malaise/fatigue (feels tired today.) And shortness of breath (chronic, not with exertion, tires easily. Not changed from baseline.) Treatment included: water, snacks and reassurance/observation for about 40 minutes Follow up response to treatment: excellent. Patient discharge: Stable to go home and follow up with PCP. Therapeutic measures were taken as a result of tired/fatigue, malaise and shortness of breath. The outcome of the events was unknown.  No follow-up attempts are Possible. No further information is expected.
Sex: F
Vaccine: COVID19
Symptoms: Arthralgia, Sinusitis
Clinical narrative: sinusitis; soreness in the shoulder on the side she received the injection; This is a spontaneous report from a contactable nurse (patient). This female patient of unspecified age received her first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE) via unspecified route of administration on 10Feb2021 at single dose for Covid-19 immunization. Relevant medical history included sinus infection on an unknown date ("before") treated with antibiotics ("generally the antibiotics help"). Concomitant medications were not reported. On an unknown date the patient experienced soreness in the shoulder on the side she received the injection. a couple of days ago, she reports soreness on the left side of her face, her eye was hurting and had a slightly sore throat. She noticed swelling in her eye, face, had a headache and pain. Clarified her eye was aching. Her left cheek and side of face was swollen. She visited the doctor who said it was sinusitis and gave her antibiotic: amoxicillin/clavulanic acid (AUGMENTIN) every 12hours for 10 days since 04Mar2021. The second dose of vaccine was planned on 08Mar2021. The outcome of the events was unknown.  Information about lot/batch number has been requested.
Age: 74.0
Sex: F
Vaccine: COVID19
Symptoms: Body temperature, Cough, Diarrhoea, Headache, Oropharyngeal pain
Clinical narrative: I feel a very slight sore throat; slight cough; Slight diarrhea; mild headache; body temperature 97.2; This is a spontaneous report from a contactable consumer, the patient. A 74-years-old female patient received the first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EL9267), via an unspecified route of administration, administered in left arm on 18Feb2021 (at the age of 74-years-old) as a single dose for covid-19 immunization. The patient medical history was not reported. Concomitant medications included nebivolol hydrochloride (BYSTOLIC) 10 mg; losartan 25mg; rosuvastatin 10mg. The patient was not pregnant at the time of vaccination. The patient had no other vaccine within four weeks. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. On 04Mar2021, the patient reported 'I feel a very slight sore throat, slight cough, mild headache, slight diarrhea, body temperature 97.2, was this a normal reaction 2 weeks after first covid vaccine'. The patient did not receive any treatment.  The outcome of the events was unknown.  No follow-up attempts are possible; No further information is expected.
Age: 71.0
Sex: F
Vaccine: COVID19
Symptoms: Chills, Diarrhoea, Dizziness, Fatigue, Headache
Clinical narrative: Extreme diarrhea; vomiting; sore throat; dizziness; headache; chills; tiredness; low grade fever; body aches; This is a spontaneous report from a contactable consumer (Patient).  A 71-year-old non pregnant female patient received second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection: Lot number: EN6199) via an unspecified route of administration on 03Mar2021 at 11:45 am, in the left arm (at the age 71-year-old) as a single dose for COVID-19 immunisation. Patient received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection: Lot number: EN5318) on 10Feb2021 at 11:45 am in the left arm (at the age 71-year-old) as a single dose for COVID-19 immunisation. Patient's medical history included Irritable bowel syndrome, allergy to Amoxicillin. Patient's concomitant medications were not reported. Patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. Patient's 2 weeks prior medication included Bupropion, Atenolol, butalbital, red yeast rice. Prior to vaccination, patient was not diagnosed with COVID-19. COVID prior vaccination was none. Since the vaccination, patient had not been tested for COVID-19. COVID tested post vaccination was none. On 04Mar2021 at 1:00 am, the patient experienced extreme diarrhea, vomiting, sore throat, dizziness, headache, chills, tiredness, low grade fever, body aches. The patient did not take any treatment medication for the events. The outcome of events was not recovered.  No follow-up attempts are possible; No further information is expected.
Age: 71.0
Sex: F
Vaccine: COVID19
Symptoms: Myalgia, Oropharyngeal pain, Pyrexia, Vomiting
Clinical narrative: Extreme diarrhea; vomiting; sore throat; dizziness; headache; chills; tiredness; low grade fever; body aches; This is a spontaneous report from a contactable consumer (Patient).  A 71-year-old non pregnant female patient received second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection: Lot number: EN6199) via an unspecified route of administration on 03Mar2021 at 11:45 am, in the left arm (at the age 71-year-old) as a single dose for COVID-19 immunisation. Patient received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection: Lot number: EN5318) on 10Feb2021 at 11:45 am in the left arm (at the age 71-year-old) as a single dose for COVID-19 immunisation. Patient's medical history included Irritable bowel syndrome, allergy to Amoxicillin. Patient's concomitant medications were not reported. Patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. Patient's 2 weeks prior medication included Bupropion, Atenolol, butalbital, red yeast rice. Prior to vaccination, patient was not diagnosed with COVID-19. COVID prior vaccination was none. Since the vaccination, patient had not been tested for COVID-19. COVID tested post vaccination was none. On 04Mar2021 at 1:00 am, the patient experienced extreme diarrhea, vomiting, sore throat, dizziness, headache, chills, tiredness, low grade fever, body aches. The patient did not take any treatment medication for the events. The outcome of events was not recovered.  No follow-up attempts are possible; No further information is expected.
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Asthenopia
Clinical narrative: eye fatigue after 1st dose; This is a spontaneous report from a contactable consumer reported for herself that. A 68 age and unit: unknown male patient received first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Formulation: Solution for injection, Batch/Lot number was not reported) via an unspecified route of administration on an unspecified date as SINGLE DOSE for covid-19 immunization. The patient medical history was not reported. The patient is sensitive to medication like Flu shot. Patient concomitant medications were not reported.  He experienced eye fatigue after first dose eyes started feeling fatigued 2 weeks later and continued until getting 2nd dose. He is very sensitive to medications for example flu shot usually makes me feel yucky for about a week. Patient asking how long symptoms are expected to last. Outcome of the event eye fatigue was unknown.  No follow-up attempts are possible; information about lot/batch number cannot be obtained.
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Malaise
Clinical narrative: eye fatigue after 1st dose; This is a spontaneous report from a contactable consumer reported for herself that. A 68 age and unit: unknown male patient received first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Formulation: Solution for injection, Batch/Lot number was not reported) via an unspecified route of administration on an unspecified date as SINGLE DOSE for covid-19 immunization. The patient medical history was not reported. The patient is sensitive to medication like Flu shot. Patient concomitant medications were not reported.  He experienced eye fatigue after first dose eyes started feeling fatigued 2 weeks later and continued until getting 2nd dose. He is very sensitive to medications for example flu shot usually makes me feel yucky for about a week. Patient asking how long symptoms are expected to last. Outcome of the event eye fatigue was unknown.  No follow-up attempts are possible; information about lot/batch number cannot be obtained.
Age: 61.0
Sex: M
Vaccine: COVID19
Symptoms: Pain in extremity, Vaccination site erythema
Clinical narrative: Nothing major; slight redness at injection site and a sore arm for 24 hours; Sore arm; This is a spontaneous report from a contactable consumer (patient). A 61-year-old male patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection, Batch/Lot Number: EN6195), via an unspecified route of administration on 04Mar2021 12:30 as unknown, single for COVID-19 immunization. Medical history and concomitant medications were not reported. The patient has not had other vaccine in four weeks. The patient has no history of COVID prior vaccination. The patient was not COVID tested post vaccination. The patient experienced nothing major; slight redness at injection site and a sore arm for 24 hours on an unspecified date. The outcome of the events was unknown.   No follow-up attempts are possible. No further information is expected.
Age: 51.0
Sex: F
Vaccine: COVID19
Symptoms: Dizziness, Headache, Oxygen saturation, Respiratory rate, Respiratory rate increased
Clinical narrative: lightheadedness; headache; vision changes; increased respirations; This is a spontaneous report from a non-contactable healthcare professional. A 51-year-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection; Batch/Lot number: EN6205, Expiration date was not reported), intramuscularly on an unspecified date (at the age of 51-years-old) as 1st dose, single dose for COVID-19 immunisation. Medical history included asthma (often triggered by stress and does have albuterol inhaler on hand) from an unknown date. The patient's concomitant medications were not reported. On an unspecified date, the patient experienced lightheadedness, headache, vision changes and increased respirations. It was reported that during the 15-minute waiting period after the injection, the patient began to experience lightheadedness, headache, vision changes and increased respirations. The patient denied rash, hives, difficulty swallowing, wheezing, throat tightness and hoarseness. The patient has a history of asthma often triggered by stress and does have albuterol inhaler on hand but has not used today. The patient denied frequent use of albuterol inhaler. Treatment included was water and TYLENOL 1000mg. The followup response to treatment was good. The patient's symptoms all resolved prior to discharge. The patient's O2 remained 99-100%, denied difficulties breathing and respirations decreased while she was in the bay. The patient was discharged, stable to go home and for follow up with PCP. The outcome of the events was recovered.  No follow-up attempts are possible. No further information expected.
Age: 51.0
Sex: F
Vaccine: COVID19
Symptoms: Visual impairment
Clinical narrative: lightheadedness; headache; vision changes; increased respirations; This is a spontaneous report from a non-contactable healthcare professional. A 51-year-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection; Batch/Lot number: EN6205, Expiration date was not reported), intramuscularly on an unspecified date (at the age of 51-years-old) as 1st dose, single dose for COVID-19 immunisation. Medical history included asthma (often triggered by stress and does have albuterol inhaler on hand) from an unknown date. The patient's concomitant medications were not reported. On an unspecified date, the patient experienced lightheadedness, headache, vision changes and increased respirations. It was reported that during the 15-minute waiting period after the injection, the patient began to experience lightheadedness, headache, vision changes and increased respirations. The patient denied rash, hives, difficulty swallowing, wheezing, throat tightness and hoarseness. The patient has a history of asthma often triggered by stress and does have albuterol inhaler on hand but has not used today. The patient denied frequent use of albuterol inhaler. Treatment included was water and TYLENOL 1000mg. The followup response to treatment was good. The patient's symptoms all resolved prior to discharge. The patient's O2 remained 99-100%, denied difficulties breathing and respirations decreased while she was in the bay. The patient was discharged, stable to go home and for follow up with PCP. The outcome of the events was recovered.  No follow-up attempts are possible. No further information expected.
Age: 71.0
Sex: M
Vaccine: COVID19
Symptoms: Vaccination site haemorrhage
Clinical narrative: blood splotches/ some splotches of what looked like blood on the towel; This is a spontaneous report from a contactable consumer reporting for himself. A 71-years-old male patient received the second dose of BNT162B2 Pfizer-BioNTech COVID-19 mRNA Vaccine via intramuscular route on an unspecified date, at 71 years of age, (Batch/Lot number was not reported) for COVID-19 immunization. The patient's medical history was not reported. Concomitant medication included acetaminophen twice a day, one in the morning and one in the evening, taken for an unspecified indication, since an unknown date. The patient reported that the nurse put the little Band-Aid where she gave the shot. About 2 hours (or maybe a little more) after his second dose, he came home and took a hot shower and the band-aid fell off and when he was drying himself he noticed some blood splotches/some splotches of what looked like blood on the towel and he didn't see any bleeding from that spot. He thinks it was from the spot where the injection was given. It didn't continue to bleed. The event was assessed as non-serious. The event outcome was unknown at the time of the report.  No follow-up attempts are possible; information about lot/batch number cannot be obtained.
Age: 40.0
Sex: M
Vaccine: COVID19
Symptoms: Pain in extremity
Clinical narrative: Sore arm; This is a spontaneous report from a contactable consumer (patient). A 40-year-old male patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection; Batch/Lot number: EN6205, Expiration Date: not reported), via an unspecified route of administration on 04Mar2021 at 09:15 (at the age of 40 years old) as first dose, single for COVID-19 immunisation in a Pharmacy or Drug Store.Medical history included high blood pressure from an unknown date. The patient's concomitant medications were not reported.  The patient did not receive any other vaccines in 4 weeks, has no known allergies and prior to vaccine the patient was not diagnosed with COVID-19. On 04Mar2021 at 14:00 (reported as 02:00PM), the patient experienced sore arm. No treatment was received for the adverse event and since vaccination, the patient has not been tested for COVID-19. Outcome of the event was recovered on an unspecified date.  No follow-up attempts are possible. No further information is expected.
Sex: M
Vaccine: COVID19
Symptoms: Headache, Hypoaesthesia
Clinical narrative: numbness in right forearm; headache; This is a spontaneous report from a non-contactable healthcare professional. A 53-year-old male patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection; Batch/Lot number: EN6205, Expiration date was not reported), via an unspecified route of administration on an unspecified date as 1st dose, single dose for COVID-19 immunisation. The patient's medical history and concomitant medications were not reported. On an unspecified date, the patient experienced numbness in right forearm and headache. It was reported that during the 15-minute waiting period after the injection, the patient began to experience numbness in right forearm and headache. He denied difficulty breathing, difficulty swallowing, itching and lightheadedness. Treatment included was Tylenol 1000 mg and water. The follow up response to treatment was good and symptoms were completely resolved. The patient reported that he would take Ibuprofen in the evening if he experiences some numbness in the right forearm or fingers. He denied symptoms of headache and numbness; resolved prior to discharge. The reporter walked with the patient to exit the facility. The patient was discharged, stable to go home and for follow up with PCP. The outcome of the events was recovered.  No follow-up attempts are possible. No further information expected.
Age: 67.0
Sex: M
Vaccine: COVID19
Symptoms: Vitreous floaters
Clinical narrative: floaters in both eyes; This is a spontaneous report from a contactable consumer (patient). A 67-year-old male patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection; Batch/Lot Number and expiration date were not reported), via an unspecified route of administration on 04Mar2021 (at the age of 67-years-old) as first dose, single dose for COVID-19 immunisation. The patient's medical history and concomitant medications were not reported. On 04Mar2021, 10 mins after the first dose, the patient experienced floaters in both eyes. The outcome of the event was not recovered; floaters in right eye resolved however the patient continued to have significant floaters in left eye. The patient was querying if this was a known side effect.  No follow up attempts are possible; information about lot/batch number cannot be obtained.
Age: 50.0
Sex: F
Vaccine: COVID19
Symptoms: Condition aggravated, Cough, Dizziness, Headache, Nasal congestion
Clinical narrative: Dizziness; headache; congestion (which existed but got worse),; coughing (which existed but got worse); congestion (which existed but got worse); This is a spontaneous report from a contactable consumer (patient).  A 50-year-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection; Batch/Lot Number: EN6199; expiration date was not reported), via an unspecified route, administered in the left arm on 04Mar2021 09:00 (at the age of 50-years-old) as first dose, single dose for COVID-19 immunisation at a Public Health Department. Medical history included hypothyroidism, hypertension, joint pain, reflux and insomnia, all from an unknown date and unknown if ongoing; and congestion and coughing, both are ongoing. Concomitant medications included meloxicam and amlodipine-olmesartan; both taken for an unspecified indication, start and stop dates were not reported. The patient was not pregnant at the time of vaccination. No other vaccine was given to the patient in four weeks. The patient had no COVID prior vaccination and was not tested for COVID post vaccination. The patient has no known allergies. On 04Mar2021 09:00 AM, the patient experienced dizziness, headache, congestion (which existed but got worse) and coughing (which existed but got worse). No treatment was taken as a result of the events. The outcome of the events was not recovered.  No follow-up attempts are possible. No further information is expected.
Age: 64.0
Sex: F
Vaccine: COVID19
Symptoms: Dizziness, Rhinorrhoea
Clinical narrative: Slightly dizziness; running nose; This is a spontaneous report from a contactable consumer or other non hcp (patient herself). A 64-year-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection, lot number: EN6205, expiration date not reported), via an unspecified route of administration, administered on the left arm on 03Mar2021 16:15 (at the age of 64-years-old), as first dose, single dose for COVID-19 immunisation. Medical history included high blood pressure (hypertension). The patient previously took meloxicam (manufacturer unknown) and experienced drug hypersensitivity. The patient received other unspecified medications within 2 weeks of vaccination. The patient was not pregnant at the time of vaccination. Prior to vaccination, the patient was not diagnosed with COVID-19; and since the vaccination, has not been tested for COVID-19. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. The patient experienced slightly dizziness and running nose on 05Mar2021 07:00. Events did not result to physician office visit and emergency room visit. No treatment was given as a result of the events. The outcome of all events reported was unknown.  No follow-up attempts are possible. No further information is expected.
Age: 62.0
Sex: F
Vaccine: COVID19
Symptoms: Chills, Cough, Headache
Clinical narrative: chronic persistent coughing; strong headache; chills; This is a spontaneous report from a contactable consumer (patient). A 62-year-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection; Batch/Lot number: EL9266, Expiration Date: not reported), via an unspecified route of administration, administered in right arm on 03Mar2021 at 13:45 (reported as 01:45 PM) (at the age of 62 years old) as first dose, single for COVID-19 immunisation in a Health Clinic. Medical history included lobectomy on 31Aug2020 and COVID-19 from an unknown date. Patient was not pregnant at the time of vaccination and has no known allergies. Concomitant medication included bupropion hydrochloride (WELLBUTRIN) taken for an unspecified indication, start and stop date were not reported. The patient did not receive any other vaccines in 4 weeks. On 04Mar2021 at 14:00 (reported as 02:00PM), the patient experienced chronic persistent coughing, strong headache, and chills. No treatment was received for the adverse event. Since vaccination, the patient has not been tested for COVID-19. Outcome of all of the events was recovering  No follow-up attempts are possible; information about lot/batch number cannot been obtained.
Age: 49.0
Sex: M
Vaccine: COVID19
Symptoms: Chills, Malaise, Nausea, Pain, Pyrexia
Clinical narrative: Fever; Chills; body aches; nausea; feeling unwell; This is a spontaneous report from a contactable consumer or other non hcp (patient himself). A 49-year-old male patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection, lot number: EN6203, expiration date not reported), via an unspecified route of administration, administered on the left arm on 04Mar2021 12:45 (at the age of 49-years-old), as first dose, single dose for COVID-19 immunization. Medical history included anxiety. Concomitant medication included buspirone (manufacturer unknown) taken for an unspecified indication, start and stop date were not reported. Patient has no reported allergies. Prior to vaccination, the patient was not diagnosed with COVID-19; and since the vaccination, has not been tested for COVID-19. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. The patient experienced fever, chills, body aches, nausea, and feeling unwell on 04Mar2021 15:00. Events did not result to physician office visit and emergency room visit. No treatment was given as a result of the events. The outcome of all events reported was not recovered.  No follow-up attempts are possible. No further information is expected.
Age: 72.0
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site erythema, Vaccination site pain
Clinical narrative: red sore at site of injection; red sore at site of injection; This is a spontaneous report from a contactable healthcare professional (patient). A 72-year-old non-pregnant female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection; Batch/Lot number and Expiration date were not reported), via an unspecified route of administration (administered on the left arm) on 11Feb2021 14:00 (at the age of 72-years-old) as 1st dose, single dose for COVID-19 immunisation. Medical history included low thyroid from an unknown date and unknown if ongoing. The patient's concomitant medications were not reported. The patient has no known allergies. The patient has no other medications in two weeks. Prior to vaccination, the patient has not been diagnosed with COVID-19. The patient didn't receive any other vaccines within 4 weeks prior to COVID vaccine. The patient experienced red sore at site of injection on 11Feb2021 15:00 (with reported adverse event date: 12Feb2021). It was reported that the patient still has redness and slight sore. No treatment was received for the events. Since the vaccination the patient has not been tested for COVID-19. The outcome of the events was not recovered.   No follow-up attempts are possible; information about lot/batch number cannot be obtained.
Age: 23.0
Sex: M
Vaccine: COVID19
Symptoms: Dizziness
Clinical narrative: lightheadedness; This is a spontaneous report from a non-contactable health care professional (other HCP). A 23-year-old male patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection; Batch/Lot Number: EN6205; Expiration date was not reported), via an unspecified route of administration on an unspecified date (at the age of 23-years-old) as first dose, single dose for COVID-19 immunisation. Medical history included lightheaded from an unknown date and unknown if ongoing; it was reported that the patient stated the he always gets lightheaded when he gets a shot. The patient's concomitant medications were not reported. On an unspecified date, during the patient's 15-minute waiting period after the injection, the patient experienced lightheadedness. The patient denied difficulty breathing, difficulty swallowing, throat tightness, nausea and any episodes of syncope in the past. The outcome of the event was recovered on an unspecified date; lightheadedness resolved prior to discharge.  No follow-up attempts are possible. No further information is expected.
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site pain, Vaccination site swelling
Clinical narrative: pain on injection site; swelling on injection site; This is a spontaneous report from a contactable consumer or other non hcp (patient herself). A female patient of an unspecified age received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection, batch/lot number, and expiration date not reported), via an unspecified route of administration on 02Mar2021, as first dose, single dose for COVID-19 immunisation. The patient's medical history and concomitant medications were not reported. The patient experienced pain on injection site and swelling on injection site on an unspecified date on Mar2021. Patient stated that on the fact sheet Pfizer stated that she should report any side effects that she has experienced. Patient added that she called just to report side effects she has experienced- pain and swelling on injection site 3-4 hours after her vaccine which lasted for a day and a half (or 36 hours) on an unspecified date on Mar2021. Patient was scheduled to get her second dose this 30March2021. The outcome of all events was recovered on an unspecified date on Mar2021.  No follow-up attempts are possible; information about lot/batch number cannot be obtained.
Sex: F
Vaccine: COVID19
Symptoms: Arthralgia
Clinical narrative: experienced "a little pain" in her shoulder that day and the next morning; This is a spontaneous report from a contactable consumer (patient). A 66-years-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection; Batch/Lot number and Expiration Date: not reported), via an unspecified route of administration on an unspecified date as first dose, single for COVID-19 immunisation. The patient's medical history and concomitant medications were not reported. On an unspecified date, the patient experienced "a little pain" in her shoulder that day of the vaccination and the next morning. The patient would like to know who like to know how effective her first dose of the BNT162B2 vaccine was. Caller was concerned about the amount of protection she had against COVID-19 now that she has had her first dose because she was supposed to go for an eye  appointment next Thursday (as reported) and was concerned being around a bunch of people. Caller states that her brother states it's 20% or 40%, and also states that doctor said it was "more than that." Outcome of the event was unknown.  No follow-up attempts are possible; information about lot/batch number cannot be obtained.
Sex: F
Vaccine: COVID19
Symptoms: COVID-19, Cough, Discomfort, Ear pain, Headache
Clinical narrative: pain and discomfort is greater with the post-vaccination side effects; pain and discomfort is greater with the post-vaccination side effects; she has not being able to sleep in two nights.; throat inflammation; nasal congestion; coughing; she developed headache / forehead pain; throat pain; pain in the internal ear; some mild allergies; she developed pain on her arm; This is a spontaneous report from a contactable consumer (patient). A female patient of an unspecified age received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection; Batch/Lot Number and expiration date were not reported), via an unspecified route on 28Feb2021 (reported as Sunday) as first dose, single dose for COVID-19 immunisation. Medical history included COVID-19 with the following symptoms: mild flu, sneezing, headache and body aches from an unknown date (reported as near February 5th) and unknown if ongoing. The patient's concomitant medications were not reported. The patient experienced pain on her arm on 28Feb2021; some mild allergies (reported as suffers from "common allergies") on 01Mar2021 (reported as Monday); headache, throat pain and pain in the internal ear on 04Mar2021 (reported as Thursday); forehead pain, throat inflammation, nasal congestion and coughing on 05Mar2021 (reported as today); and pain and discomfort (reported as greater with the post-vaccination side effects than with the COVID-19 infection) and not being able to sleep in two nights on an unspecified date. Therapeutic measure, paracetamol (TYLENOL), was taken as a result of the events. The patient underwent lab tests and procedures which included COVID-19: Positive on an unspecified date (reported as near February 5th). The outcome of the events pain on her arm, pain and discomfort is greater with the post-vaccination side effects and not being able to sleep in two nights was unknown; while the outcome of events some mild allergies, headache, throat pain, pain in the internal ear, forehead pain, throat inflammation, nasal congestion and coughing was not recovered. The patient has not presented fever, stopped working on Wednesday and wanted to know if these were reported side effects of the vaccine and how long could these side effects last. The patient has an appointment with her physician on March 17th.   No follow-up attempts are possible; information about lot/batch number cannot be obtained.